MADRID — Patients with advanced endometrial cancer had less disease progression and lived longer when they received the immune checkpoint inhibitor (ICI) atezolizumab (Tecentriq) i… Read More
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete… Read More
Image Source: www.psychreg.org
New Study Reveals Insights into Difficult-to-Treat Neuroendocrine Tumors
Neoadjuvant Immune Checkpoint Blockade Shows Promise in Cancer Treatment
In a groundb… Read More
Kaala Paani takes place in 2027 and is centered around a fictional epidemic called LHF-27 caused by the contamination of a lake in the Andaman and Nicobar Islands. Even though the warning si… Read More
The global non-small cell lung cancer (NSCLC) treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 20… Read More
The impact of immunotherapy, specifically immune checkpoint inhibitors, in advanced and metastatic cancer quickly led to interest in using the therapy in earlier-stage disease. Most recent… Read More
Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compe… Read More
Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an a… Read More
Delveinsight Business Research LLP
DelveInsight’s “Metastatic Merkel Cell Carcinoma Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-dept… Read More
[Sept. 18, 2023: Vinod P. Balachandran, Memorial Sloan Kettering Cancer Center] The key to these vaccines appears to be proteins in the pancreatic tumors, called neoantigens, which alert th… Read More
The T cell receptor (TCR) therapy market refers to the global industry involved in the development, manufacturing, and commercialization of therapies that utilize T cell receptors for the tr… Read More
On August 23, 2023, BOXER CAPITAL, LLC, a San Diego-based investment firm, reduced its stake in ITeos Therapeutics Inc (
ITOS, Financial). The firm sold 350,000 shares at a price of $16.26 p… Read More